Hepatology: Harvard University

Total Score People Score Events Score
102 89 30
Date Event Presentation Speakers
January 4, 2017 Innovations in Gastroenterology, 2017 Symposium A pathophysiologic approach to treating obesity: Michael Wolfe, USA Michael S. Wolfe
November 7, 2016 Frontiers in Cancer Science 2016 LORENZ POELLINGER KEYNOTE TALK William G Kaelin
October 24, 2015 19th International Meeting of the European Society of Gynaecological Oncology (ESGO 2015) Parallel: Management of intermediate risk of endometrial cancer Michael J. Birrer
April 10, 2015 Asian Oncology Summit 2015 Systemic therapy for cholangiocarcinoma: novel targets Andrew Zhu
Next generation of targeted therapy for NSCLC Pasi A Janne
Optimal management of metastatic hepatocellular carcinoma Andrew Zhu
December 5, 2014 24th World Congress of the International Association of Surgeons, Gastroenterologists and Oncologists Current topics in translational GI oncology Carlos Fernández-del Castillo, Andrew Zhu
State-of-the-art imaging and genomics in oncology Dushyant Sahani
Abdominal malignancies - present reality and future perspectives for therapy 1 Gregory Lauwers
Abdominal malignancies - present reality and future perspectives for therapy 2 Gregory Lauwers
February 17, 2014 Sao Paulo Advanced School in Oncogenesis and Translational Medicine (ESPCA) + Bioinformatics (Mini-course) Molecular-based classification of glioblastoma – Prof. Dr. Cameron Brennan Cameron W Brennan
January 30, 2014 Genitourinary Cancers Symposium General Session 3: Prostate Cancer- Tumor Board Audience Challenge (ARS) A. Oliver Sartor
General Session 5: Advances in Therapy for Urothelial Carcinoma Jonathan Rosenberg
October 27, 2013 Nature - CNIO Cancer Symposium: Frontiers in Tumour Heterogeneity and Plasticity Clinical and functional relevance of intratumor heterogeneity in breast cancer Kornelia Polyak
Targeting Clonal Heterogeneity and Signaling Networks in Myeloid Malignancies Ross Levine
May 31, 2013 ASCO Annual Meeting 2013 Optimizing the Role of Advanced Practice Professionals in Oncology Practice Lawrence N. Shulman
Hot Pathways for Targeted Therapy of B-Cell Malignancies James E. Bradner
Beyond Trastuzumab and Lapatinib: New Options for HER2-Positive Breast Cancer Ian E. Krop
Clinical Management, Molecular Alterations, and Future Perspectives in Urothelial Cancer David Kwiatkowski
Cancer Stem Cells: A New and Better Target in Pediatric Oncology? Scott A. Armstrong, George Daley
Reaping the Rewards of the Cancer Genome Atlas Project Levi A Garraway
Improving Cancer Care through Health Information Technology: Ethics and Practicality Lawrence N. Shulman
Education Sessions Robert G Maki, Stephen T Sonis
Education Sessions Deborah Schrag
Education Sessions Tracy T Batchelor
Education Sessions Michael B. Atkins, Jennifer A. Ligibel
Educations Sessions Monica M. Bertagnolli
Education Sessions Bruce E. Johnson, Elizabeth R. Gerstner
May 28, 2013 NGS Translate In Vivo Dynamics of the Microbiota: Development of Computational Models for Time Series Analyses Lynn Bry
April 6, 2013 AACR Annual Meetings EPIGENETIC TARGETS FOR CANCER Anjana Rao, James E. Bradner
Developmental Origins of Cancer Chairperson: Richard J. Gilbertson, St. Jude Children's Research Hospital, Memphis, TN Stuart H. Orkin
Blood-Based Molecular Analysis of Cancer Daniel A Haber
Intrinsic and Microenvironment-Dependent Adaptive Responses that Regulate Drug Resistance Chairperson: Joan S. Brugge, Harvard Medical School, Boston, MA Joan S Brugge
The Interface Between Development and Cancer Using Model Organisms Chairperson: Michael M. Shen, Columbia University, New York, NY Leonard I. Zon
Emerging Single Cell Technologies in Cancer Research Chairperson: Garry P. Nolan, Stanford University School of Medicine, Stanford, CA Claude Lechene
Mutations in Epigenetic Regulators in Cancer Chairperson: Scott A. Armstrong, Memorial Sloan-Kettering Cancer Center, New York, NY Scott A. Armstrong
Mitotic Checkpoints Driving Cancer Therapeutic Strategies Chairperson: Peter K. Jackson, Genentech, Inc., South San Francisco, CA Timothy J Mitchison
Translational Control and Stress Response Pathways in Cancer Chairperson: Davide Ruggero, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA Karen Cichowski
Developmental and Molecular Origins of Brain Tumors Co-Chairpersons: Suzanne J. Baker, St. Jude Children's Research Hospital, Memphis, TN, and Cameron W. Brennan, Memorial Sloan-Kettering Cancer Center, New York, NY Cameron W Brennan
Synthetic Lethality and Genetic Approaches to Cancer Chairperson: Stephen J. Elledge, Harvard Medical School, Boston, MA Stephen J Elledge
Structural Aberrations in a Thousand Tumors Chairperson: Raju Kucherlapati, Harvard Medical School, Boston, MA Raju Kucherlapati
The Stanley J. Korsmeyer Memorial Symposium: Targeting Cell Death Pathways for Cancer Therapy Chairperson: Anthony G. Letai, Dana-Farber Cancer Institute, Boston, MA Anthony G. Letai
The Origins and Clinical Implications of Precancerous Lesions Chairperson: Cory Abate-Shen, Columbia University Irving Comprehensive Cancer Center, New York, NY Kornelia Polyak
Noncoding RNAs and Cancer Chairperson: Phillip A. Sharp, David H. Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA Jeannie T. Lee
New Cancer Vaccines Chairperson: Glenn Dranoff, Dana-Farber Cancer Institute, Boston, MA Glenn Dranoff
The Origins and Neoplastic Progression of Barrett's Esophagus Co-Chairpersons: Timothy C. Wang, Columbia University Medical Center, New York, NY, and Brian J. Reid, Fred Hutchinson Cancer Research Center, Seattle, WA Frank McKeon
Molecular Basis and Therapeutic Targeting of Bone Metastasis Co-Chairpersons: Yibin Kang, Princeton University, Princeton, NJ, and Matthew R. Smith, Massachusetts General Hospital Cancer Center, Boston, MA Matthew Smith
Molecular and Cellular Determinants of Brain Metastasis Co-Chairpersons: William C. Hahn, Dana-Farber Cancer Institute, Boston, MA, and Joan Massagué, Memorial Sloan-Kettering Cancer Center, New York, NY Rakesh K Jain, William C Hahn
Avatar: Individualized Human Cancer Models in Mice Kwok-Kin Wong
Next-Generation Therapeutic Modeling in Mice Pier Paolo
The Utility of Cancer Cell Line Screens for Modeling Drug Sensitivities Moderator: Jeffrey Settleman, Genentech, Inc., South San Francisco, CA Levi A Garraway
Clinical Trials Based on Mutations versus Histology William R Sellers, Lewis C Cantley
Human Papillomavirus: Beyond Cervical Cancer Chairperson: Maura L. Gillison, The Ohio State University Comprehensive Cancer Center, Columbus, OH Peter M Howley
From Chemistry to the Clinic: Pathways for Drug Discovery and Development, Part 1: Targeting Mechanisms of Therapeutic Resistance Chairperson: Matt V. Lorenzi, Janssen Research & Development, Spring House, PA Kwok-Kin Wong
Credentialing Response Biomarkers for Signal Transduction Inhibitors Chairperson: Neal Rosen, Memorial Sloan-Kettering Cancer Center, New York, NY Anthony G. Letai
Therapeutic Nanotechnology Chairperson: Gregory Lanza, Washington University, St. Louis, MO Omid C Farokhzad
Rational Combination Therapies in Cancer Chairperson: Gordon B. Mills, The University of Texas MD Anderson Cancer Center, Houston, TX Scott A. Armstrong
The Next Frontier in Targeted Therapy for Melanoma Chairperson to be announced Lynda Chin
New Paradigms in Molecular Pharmacology Chairperson: Angela N. Koehler, Broad Institute of MIT and Harvard, Cambridge, MA James E. Bradner
Metabolism and Signaling in Cancer Chairperson: Eyal Gottlieb, The Beatson Institute for Cancer Research, Glasgow, United Kingdom Nika N. Danial
Immune Modulation in the Tumor Microenviroment Chairperson: James P. Allison, Memorial Sloan-Kettering Cancer Center, New York, NY Raghu Kalluri
Cancer Imaging in Mice and Men Andrew L. Kung, Dana-Farber Cancer Institute, Boston, MA Andrew Kung
2-Oxoglutarate-Dependent Dioxygenases as Targets of Cancer-Causing Mutations and Cancer Therapeutics William G. Kaelin, Jr., Dana-Farber Cancer Institute, Boston, MA William G Kaelin
Tumor-Secreted Factors Chairperson: David C. Lyden, Weill Cornell Medical College of Cornell University, New York, NY Xandra O Breakefield
Autocrine Activation of MET and Strategies to Overcome Adaptation for the Targeted Therapy of Acute Myeloid Leukemia A. Thomas Look, Dana-Farber Cancer Institute, Boston, MA Thomas A. Look
Stapled Peptides as Next-Generation Therapeutics Gregory L. Verdine, Harvard University, Cambridge, MA Gregory L Verdine
Prognostic and Predictive Biomarkers of Triple-Negative Breast Cancer Andrea L. Richardson, Brigham and Women's Hospital, Boston, MA Andrea L Richardson
Cancer Omics Beyond the Genome Sunney Xie
16th Annual Grant Writing Workshop Building Presence and Leadership through Empowered Communication Co-Chairpersons: Martine J. Piccart, Institut Jules Bordet, Brussels, Belgium, and Victoria M. Richon. Epizyme, Inc., Wellesley Hills, MA Kornelia Polyak
Patient-Derived Xenograft Models of Cancer: Where Are We Going? Chairperson: Matthew J. Ellis, Washington University Siteman Cancer Center, St. Louis, MO Tan Ince
WICR Career Mentoring Session Joan S Brugge
January 31, 2013 5th Immunotherapeutics & Immunomonitoring KEYNOTE PRESENTATION Jeffrey J. Popma
January 20, 2013 Tumor Invasion and Metastasis GEM models in translational research Lynda Chin
Regulation of metastasis via tumor-stromal interactions Randolph S Watnick
Session 8: Treatment of Metastatic Cancer Bruce R. Zetter
September 13, 2012 International Society of Gastrointestinal Oncology Transarterial Embolic Therapy for Liver-Predominant NETs: Bland vs. Chemoembolization vs. Radioembolization David R Liu
December 13, 2011 New Horizons in Cancer Research: Biology to Prevention to Therapy Welcome and Opening Remarks Judy Garber
Epigenetics of hormone dependence Myles Brown
June 20, 2011 Cancer Proteomics 2011 - Systems Biology, Developmental Models and Data Integration Interactome networks & human disease Marc Vidal
November 7, 2010 Ninth Annual International Conference on Frontiers in Cancer Prevention Research PARP inhibitors: Early promise in breast and ovarian cancer prevention Judy E Garber
Clinical trials in neurofibromatosis 1 and 2 Scott Plotkin
January 22, 2010 2010 Gastrointestinal Cancers Symposium General Session IV: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract: Prevention, Screening, and Diagnosis Sapna Syngal
Normalizing the Tumor Microenvironment to Improve Drug Delivery and Efficacy Rakesh K Jain
Newer Radiation Techniques in the Treatment of Hepatobiliary and Pancreatic Cancers Harvey J. Mamon
Advanced Imaging Techniques Dushyant Sahani
Gastroenterologist William R. Brugge
Advanced Imaging Techniques Dushyant Sahani
October 23, 2009 Current Topics in Surgery The Johann Ehrenhaft Lecture: Evolution of the treatment of mitral valve disease Lawrence Cohn
September 23, 2009 Track 3: Advancing Cancer Therapy : Second Annual Translational Cancer Medicine The Use of Genetically Engineered Mice for Preclinical Testing of Novel Cancer Therapeutics Kwok-Kin Wong
August 10, 2009 Second Annual Trends in Cancer Diagnostics EGFR and Beyond: Evolution of a Molecular Classification and Treatment Strategy for Lung Cancer Neal Lindeman
June 8, 2009 RNAi for Functional Screens Talk Title to Be Announced Caroline Shamu
February 5, 2009 ACI’s National Conference on Successful Strategies For Genetic AN D Molecular Diagnostic Testing SPONSORS 2:15 PM - 3:15 PM The role of Molecular diagnostic testing in managing patients with lung adenocarcinoma Neal Lindeman
How to build a successful molecular diagnostics laboratory Gyorgy Abel
April 28, 2008 Clinical Development of Therapeutic Antibodies Normalizing Tumor Vessels and Microenvironment to Treat Cancer: From the Bench to Bedside and Back Rakesh K Jain
March 2, 2008 MOLECULAR MECHANISMS IN LYMPHATIC FUNCTION & DISEASE New directions in adipocyte development Evan Rosen
February 17, 2008 GRC - Glycolipid & Sphingolipid Biology Arrival and Check-in (Office Closed 6:00 pm - 7:45 pm) Test User
Cell non-autonomous function of ceramidase in photoreceptor homeostasis Usha Acharya
November 7, 2007 Srial II: Advances and Challenges Toward Major Diseases: Extension on New Hope Nov (07-13) Session 11: Anti-Infectious Drug Discovery & Development (II) (09:00-12:20) Irene Bosch
Session 11: Identification of Novel and Effective Antiviral Treatment and zstablishment of Disease Pathogenesis: A journey of Global Gene Expression of dengue virus infection (11:20-11:40) Irene Bosch
October 17, 2007 Exploring Next Generation Sequencing: Applications and Case Studies (Oct 17-18) Genome Resequencing for Mutation Screening (13:30-18:30) Raphael Bueno
Genome Resequencing for Mutation Screening: Deep Genomic Analysis of Tumors for the Discovery of Sequence Variation: From the Surgical Suite to the Genome Sequencer (16:30-17:00) Raphael Bueno
Next-Next Generation Sequencing (10:30-12:00) Jonathan Seidman
Next-Next Generation Sequencing: Polony Multiplex Analysis of Gene Expression (PMAGE) and Mouse Hypertrophic Cardiomyopathy (11:20-11:45) Jonathan Seidman
July 7, 2007 Protein Kinases and Protein Phosphorylation Signal transduction by Stress-activated MAP Kinases Roger Davis
ERK2 signaling through DEF domain interactions induces epithelial-to-mesenchymal transition (EMT) in breast epithelial cells Christopher Dimitri
Regulation of neuronal death by protein kinase pathways Azad Bonni
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.